BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 34660263)

  • 1. Expression of Microtubule-Associated Proteins in Relation to Prognosis and Efficacy of Immunotherapy in Non-Small Cell Lung Cancer.
    Luo J; Hu Q; Gou M; Liu X; Qin Y; Zhu J; Cai C; Tian T; Tu Z; Du Y; Deng H
    Front Oncol; 2021; 11():680402. PubMed ID: 34660263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of ALOX5 in non-small cell lung cancer: A potential therapeutic target associated with immune cell infiltration.
    Zhao Q; Sun Z; Pan Y; Jing Q; Li W; Wang C
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 Mar; 48(3):311-322. PubMed ID: 37164914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and Integrate Analysis of Key Biomarkers for Diagnosis and Prognosis of Non-Small Cell Lung Cancer Based on Bioinformatics Analysis.
    Gong K; Zhou H; Liu H; Xie T; Luo Y; Guo H; Chen J; Tan Z; Yang Y; Xie L
    Technol Cancer Res Treat; 2021; 20():15330338211060202. PubMed ID: 34825846
    [No Abstract]   [Full Text] [Related]  

  • 4. Identification and validation of key genes with prognostic value in non-small-cell lung cancer via integrated bioinformatics analysis.
    Wang L; Qu J; Liang Y; Zhao D; Rehman FU; Qin K; Zhang X
    Thorac Cancer; 2020 Apr; 11(4):851-866. PubMed ID: 32059076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Periostin is associated with prognosis and immune cell infiltration in pancreatic adenocarcinoma based on integrated bioinformatics analysis.
    Chen Y; Zhang F; Zhang B; Trojanowicz B; Hämmerle M; Kleeff J; Sunami Y
    Cancer Rep (Hoboken); 2024 Feb; 7(2):e1990. PubMed ID: 38389400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated expression of mitochondrial transcription elongation factor (TEFM) predicts poor prognosis in low grade glioma-an analysis of the Cancer Genome Atlas (TCGA) dataset.
    Li S; Wang W; Zi J; Sun M; Mei W; Yang N; Zhang R; Yu M; Xiong W
    Transl Cancer Res; 2020 May; 9(5):3610-3622. PubMed ID: 35117724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analyses of expressions and prognostic values of Polo-like kinases in non-small cell lung cancer.
    Zeng Y; Li N; Liu W; Zeng M; Cheng J; Huang J
    J Cancer Res Clin Oncol; 2020 Oct; 146(10):2447-2460. PubMed ID: 32627077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression, Prognosis and Gene Regulation Network of NFAT Transcription Factors in Non-Small Cell Lung Cancer.
    Ma J; Du R; Huang Y; Zhong W; Gui H; Mao C; Song X; Lu J
    Pathol Oncol Res; 2021; 27():529240. PubMed ID: 34257525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioinformatics analysis of the transcriptional expression of minichromosome maintenance proteins as potential indicators of survival in patients with cervical cancer.
    Wu B; Xi S
    BMC Cancer; 2021 Aug; 21(1):928. PubMed ID: 34404366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of latent biomarkers in connection with progression and prognosis in oral cancer by comprehensive bioinformatics analysis.
    Reyimu A; Chen Y; Song X; Zhou W; Dai J; Jiang F
    World J Surg Oncol; 2021 Aug; 19(1):240. PubMed ID: 34384424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Up-Regulated MISP Is Associated With Poor Prognosis and Immune Infiltration in Pancreatic Ductal Adenocarcinoma.
    Huang X; Zhao L; Jin Y; Wang Z; Li T; Xu H; Wang Q; Wang L
    Front Oncol; 2022; 12():827051. PubMed ID: 35433491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Regulatory Network and Potential Role of LINC00973-miRNA-mRNA ceRNA in the Progression of Non-Small-Cell Lung Cancer.
    Guo Q; Li D; Luo X; Yuan Y; Li T; Liu H; Wang X
    Front Immunol; 2021; 12():684807. PubMed ID: 34394080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicopathological characteristics and prognostic significance of HDAC11 protein expression in non-small cell lung cancer: a retrospective study.
    Lu D; Ma Z; Huang D; Zhang J; Li J; Zhi P; Zhang L; Feng Y; Ge X; Zhai J; Jiang M; Zhou X; Simone CB; Neal JW; Patel SR; Yan X; Hu Y; Wang J
    Transl Lung Cancer Res; 2022 Jun; 11(6):1119-1131. PubMed ID: 35832445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Construction of a circular RNA-microRNA-messenger RNA regulatory network of hsa_circ_0043256 in lung cancer by integrated analysis.
    Li Y; Shi R; Zhu G; Chen C; Huang H; Gao M; Xu S; Cao P; Zhang Z; Wu D; Li X; Liu H; Chen J
    Thorac Cancer; 2022 Jan; 13(1):61-75. PubMed ID: 34806315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression Signature and Role of miR-30d-5p in Non-Small Cell Lung Cancer: a Comprehensive Study Based on in Silico Analysis of Public Databases and in Vitro Experiments.
    Gao L; He RQ; Wu HY; Zhang TT; Liang HW; Ye ZH; Li ZY; Xie TT; Shi Q; Ma J; Hu XH; Chen G
    Cell Physiol Biochem; 2018; 50(5):1964-1987. PubMed ID: 30396166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. UHRF1 Could Be a Prognostic Biomarker and Correlated with Immune Cell Infiltration in Hepatocellular Carcinoma.
    Li D; Chen B; Zeng Y; Wang H
    Int J Gen Med; 2021; 14():6769-6776. PubMed ID: 34675635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Target gene screening and evaluation of prognostic values in non-small cell lung cancers by bioinformatics analysis.
    Piao J; Sun J; Yang Y; Jin T; Chen L; Lin Z
    Gene; 2018 Mar; 647():306-311. PubMed ID: 29305979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systematic Analysis of the Prognostic Significance and Roles of the Integrin Alpha Family in Non-Small Cell Lung Cancers.
    Huang Y; Guo DM; Bu S; Xu W; Cai QC; Xu J; Jiang YQ; Teng F
    Adv Ther; 2023 May; 40(5):2186-2204. PubMed ID: 36892810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bioinformatics analysis and experimental validation of TTK as a biomarker for prognosis in non-small cell lung cancer.
    Chen J; Wu R; Xuan Y; Jiang M; Zeng Y
    Biosci Rep; 2020 Oct; 40(10):. PubMed ID: 32969465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of immuno-infiltrating MAP1A as a prognosis-related biomarker for bladder cancer and its ceRNA network construction.
    Lyu X; Qiang Y; Zhang B; Xu W; Cui Y; Ma L
    Front Oncol; 2022; 12():1016542. PubMed ID: 36408130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.